Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women and men between 18 and 89 years old who have a skin condition called stasis dermatitis, caused by high blood pressure in the veins (venous hypertension)
- People who agree to the terms of the study and sign a consent form
- People who are able to attend all required appointments for treatment and follow-up visits
- People who agree to avoid becoming pregnant during the study
- People who have already had treatment for varicose veins in the legs (using any available method) related to their venous condition
Who may not be able to join:
- People with a venous disease classification of CEAP 2 to 6, limited mobility, and no stasis dermatitis (confirm with trial site)
- People who have reduced blood flow to the limbs due to artery problems (peripheral arterial disease)
- People with a known allergy to any of the medications being used in this study
- People who have other types of skin conditions affecting the lower legs, such as allergic eczema
- People who have certain other health conditions, including diabetes, heart failure, breathing problems, high blood pressure, thyroid disorders, asthma, or migraines — or who are pregnant, breastfeeding, have pulmonary hypertension, have had deep vein thrombosis (blood clots in the veins), have a family history of blood clots, or have a known tendency for the blood to clot too easily
- People who do not agree to any of the study terms
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Eduardo Ramacciotti, MD, Ph.D, livre docente, Science Valley Research Institute
Phone: +5511950212099
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Colorimetry
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.